Try our beta test site
360 studies found for:    stem cells AND kidney disease
Show Display Options
Rank Status Study
1 Completed Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
2 Unknown  Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy
Conditions: Kidney Transplant;   Chronic Allograft Nephropathy
Intervention: Biological: mesenchymal stem cell
3 Recruiting Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease
Condition: End Stage Renal Disease
Interventions: Procedure: Kidney and hematopoietic stem cell transplantation;   Biological: hematopoietic stem cell
4 Completed Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)
Condition: Chronic Kidney Disease
Intervention: Biological: Intravenous injection
5 Not yet recruiting Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease
Condition: Moderate to Severe Chronic Kidney Disease
Intervention: Drug: Elixcyte
6 Active, not recruiting Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
Conditions: Renal Insufficiency, Chronic;   Nephrotic Syndrome
Interventions: Drug: Rituximab;   Drug: conventional therapy;   Drug: Mesenchymal stem cells
7 Recruiting Senescence in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Group 2: Dasatinib;   Drug: Group 2: Quercetin
8 Unknown  Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Other: Autologous bone marrow stem cells
9 Completed
Has Results
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
Conditions: Kidney Transplantation;   Kidney Disease;   Kidney Failure
Interventions: Drug: Alemtuzumab;   Drug: Mycophenolate mofetil;   Drug: Sirolimus;   Drug: Tacrolimus;   Procedure: Donor bone marrow stem cell infusion;   Procedure: Kidney transplant
10 Recruiting Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes and Mild CKD
Conditions: Type 2 Diabetes Mellitus;   Chronic Kidney Disease
Interventions: Drug: Canagliflozin;   Drug: Placebo
11 Completed A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Conditions: Hemoglobin SC Disease;   Sickle Cell Anemia
Intervention: Drug: Recombinant-methionyl human stem cell factor
12 Recruiting Stem Cell Collection
Condition: Stem Cells
13 Active, not recruiting MSC for Occlusive Disease of the Kidney
Conditions: Atherosclerotic Renal Artery Stenosis;   Ischemic Nephropathy;   Renovascular Hypertension
Intervention: Drug: Arterial infusion of autologous mesenchymal stem cells
14 Completed Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait
Condition: Sickle Cell Trait
Interventions: Drug: Granulocyte colony-stimulating factor;   Procedure: Leukapheresis
15 Recruiting Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
Conditions: Renal Artery Stenosis;   Ischemic Nephropathy;   Renovascular Disease;   Chronic Kidney Disease
Interventions: Drug: Mesenchymal stem cell;   Procedure: Mesenchymal stem cell delivery with stent placement
16 Recruiting Tolerance Induction in Living Donor Kidney Transplantation With Hematopoietic Stem Cell Transplantation
Condition: End Stage Renal Disease
Intervention: Procedure: Transplantation Conditioning for BMT
17 Terminated
Has Results
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   High Cholesterol
Intervention: Drug: Atorvastatin
18 Not yet recruiting Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
Conditions: End Stage Renal Disease (ESRD);   Vascular Access Complication
Intervention: Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
19 Completed Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Myelodysplastic Syndromes;   Leukemia, Myeloid, Acute;   Leukemia, Myelogenous, Chronic;   Multiple Myeloma
Interventions: Radiation: Dynamic contrast-enhanced computed tomography;   Drug: Ioversol
20 Recruiting Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis
Conditions: Glomerulosclerosis, Focal Segmental;   Renal Insufficiency, Chronic
Intervention: Biological: Autologous Cell Transplantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.